Your browser doesn't support javascript.
loading
Fabrication and characterization of solid lipid microparticles of ketoprofen
Mishra, S; Suryawanshi, R; Chawla, V; Saraf, S.
Affiliation
  • Mishra, S; Babu Banarsi Das National Institute of Technology and Management. Faculty of Pharmacy. Lucknow. India
  • Suryawanshi, R; Babu Banarsi Das National Institute of Technology and Management. Faculty of Pharmacy. Lucknow. India
  • Chawla, V; Northern India Engineering College. Faculty of Pharmacy. Lucknow. India
  • Saraf, S; Babu Banarsi Das National Institute of Technology and Management. Faculty of Pharmacy. Lucknow. India
Ars pharm ; Ars pharm;52(1): 12-15, ene.-mar. 2011. ilus, tab
Article in En | IBECS | ID: ibc-88801
Responsible library: ES1.1
Localization: BNCS
ABSTRACT
Solid lipid microparticles (SLMs) loaded with ketoprofen were prepared by single emulsion-solvent evaporation method, in which glyceryl monostearate and Tween 80 were employed. The particle size was found to be 99.80±2.1μm. Microparticles observed by scanning electron microscope (SEM) showed spherical shape. The entrapment efficiency (EE %) and drug loading capacity (DL %) were found to be 72.60±1.6 % and 17.98±0.7% respectively. Results of stability evaluation showed relatively long term stability after storage at 4˚C for 3 months. The in-vivo study revealed slightly better per cent inhibition of pain i.e. 74% in comparison with 68% produced by plain drug(AU)
RESUMEN
Las micropartículas lipídicas sólidas (MLS) cargadas con ketoprofeno se han preparado a través del método de evaporación del disolvente en emulsión simple, en el que se ha utilizado monoestearato de glicerilo y Tween 80. El tamaño de la partícula ha resultado ser de 99,80±2,1 μm. Las micropartículas observadas a través del microscopio electrónico de barrido (MEB) han mostrado una forma esférica. La eficacia de compresión (EC %) y la capacidad de concentración (CC %) del fármaco han resultado ser de 72,60±1,6% y 17,98±0,7% respectivamente. Los resultados de la evaluación de estabilidad han mostrado una estabilidad relativa a largo plazo después de una conservación a 4˚C durante 3 meses. El estudio in vivo ha revelado un ligero mejor porcentaje de inhibición del dolor, es decir, un 74% en comparación con un 68% producido por un fármaco corriente(AU)
Subject(s)
Search on Google
Collection: 06-national / ES Database: IBECS Main subject: Histology / Lipid Peroxides Type of study: Prognostic_studies Limits: Female / Humans / Male Language: En Journal: Ars pharm Year: 2011 Document type: Article
Search on Google
Collection: 06-national / ES Database: IBECS Main subject: Histology / Lipid Peroxides Type of study: Prognostic_studies Limits: Female / Humans / Male Language: En Journal: Ars pharm Year: 2011 Document type: Article